Showing results (91-100 of 162) with videos related to
Sort By:
Pageof 17
Breast Cancer Research and Treatment|January 20, 2016
Characterizing and quantifying the effects of breast cancer therapy using mathematical modelingWalter M Gregory, Christopher J Twelves, Richard Bell, et al.Science (New York, N.Y.)|May 11, 2019
Vision using multiple distinct rod opsins in deep-sea fishesZuzana Musilova, Fabio Cortesi, Michael Matschiner, et al.European Journal of Cancer Care|January 21, 2021
Strategies for improving access to clinical trials by teenagers and young adults with cancer: A qualitative study of health professionals' viewsRuth I Hart, Dorothy Boyle, David A Cameron, et al.Breast Cancer Research and Treatment|February 14, 2018
Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trialKim C Aalders, Nathan Touati, Konstantinos Tryfonidis, et al.Journal of Cancer Policy|September 7, 2024
Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patientsCalum Purdie, Gavin R C Clark, David A Cameron, et al.Hearing Research|May 24, 2023
Effects of sensorineural hearing loss on formant-frequency discrimination: Measurements and modelsLaurel H Carney, David A Cameron, Kameron B Kinast, et al.BMC Health Services Research|January 10, 2020
The challenges of making informed decisions about treatment and trial participation following a cancer diagnosis: a qualitative study involving adolescents and young adults with cancer and their caregiversRuth I Hart, David A Cameron, Fiona J Cowie, et al.Neural Development|July 10, 2012
Layer 6 cortical neurons require Reelin-Dab1 signaling for cellular orientation, Golgi deployment, and directed neurite growth into the marginal zoneRyan S O'Dell, Candida J M Ustine, David A Cameron, et al.Carcinogenesis|December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cellsFiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative GroupRobert J Paridaens, Luc Y Dirix, Louk V Beex, et al.Pageof 17